Jagsonpal Pharmaceuticals Merger & Restructuring Worth ₹40 Cr
Jagsonpal Pharmaceuticals Limited announced a buyback of up to 16,00,000 equity shares at ₹250 per share, totalling ₹40 Crore. The buyback, representing 2.38% of paid-up capital, opens on May 08, 2026, and closes on May 14, 2026.
- Value
- ₹40.00 Cr